Amplia Therapeutics (ASX:ATX) has received Australian ethics approval for the Phase 2 clinical trial of narmafotinib in combination with the chemotherapy FOLFIRINOX. …
Amplia Therapeutics secures ethics approval for pancreatic cancer trial
July 30, 2025 Australian Biotech
Latest Video
New Stories
-
A not so long list of new medicines for the November PBAC
July 31, 2025 - - Latest News -
Government admits general safety net is 'significantly higher' than comparable countries
July 31, 2025 - - Latest News -
Companies face higher rebate payments as a result of co-pay reduction
July 31, 2025 - - Latest News -
Substantial US program aims to address gaps in Hepatitis C diagnosis and cure
July 31, 2025 - - Latest News -
Amplia Therapeutics secures ethics approval for pancreatic cancer trial
July 30, 2025 - - Australian Biotech -
Plenty going on behind the scenes, but the industry so far is mostly favouring public silence
July 30, 2025 - - Latest News -
World-first study uses DNA to investigate who develops MS and why
July 30, 2025 - - Latest News